ZyVersa Therapeutics, Inc.
ZVSA
$0.20
$0.014.17%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -678.60K | -19.81M | -2.21M | -2.26M | -1.42M |
| Total Depreciation and Amortization | -- | -- | -- | -- | 0.00 |
| Total Amortization of Deferred Charges | 57.20K | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.40K | 17.90M | 188.00K | 153.90K | 275.30K |
| Change in Net Operating Assets | 190.30K | 498.80K | 501.60K | 331.00K | -68.30K |
| Cash from Operations | -413.70K | -1.41M | -1.52M | -1.77M | -1.21M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 2.05M | 200.00 | -- | 3.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.50K | -189.00K | -17.90K | 1.85M | -417.80K |
| Cash from Financing | -12.50K | 1.86M | -17.70K | 1.85M | 2.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -426.20K | 455.90K | -1.54M | 80.60K | 1.41M |